Cite
HARVARD Citation
Pang, C. et al. (2020). Sotrastaurin, a PKC inhibitor, attenuates RANKL‐induced bone resorption and attenuates osteochondral pathologies associated with the development of OA. Journal of cellular and molecular medicine. 24 (15), pp. 8452-8465. [Online].